Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06361342 · ClinicalTrials.gov registry record · NA

Smartphones Aggravating Anxiety Symptoms

A NA study of Anxiety, sponsored by Mayo Clinic.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06361342 is a NA study of Anxiety that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06361342, a NA study of Anxiety, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to assess if excessive use of smartphone apps of social media can impact a person's mental health. The study is aimed at improving the usage of smartphones which might help improve the mental health of patients. The goal is not to discourage the use of smartphones but instead to utilize smartphones in a way that they do not impact lives.

Conditions Studied

Interventions

  • BEHAVIORAL General decrease in smartphone use
  • BEHAVIORAL Avoiding Social Media Apps

Study Locations (1)

Minnesota

  • Mayo Clinic Minnesota - Rochester

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-03-08
Est. Completion 2026-12
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06361342

The ClinicalTrials.gov registry entry for NCT06361342 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (77% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which General decrease in smartphone use is the first listed.

NCT06361342 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06361342 about?

NCT06361342 is a clinical study titled "Smartphones Aggravating Anxiety Symptoms". The goal of this study is to assess if excessive use of smartphone apps of social media can impact a person's mental health. The study is aimed at improving the usage of smartphones which might help improve the mental health of patients. The goal is not to discourage the use of smartphones but inste...

What is the current status of trial NCT06361342?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-03-08. Estimated completion is 2026-12.

What conditions does trial NCT06361342 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT06361342?

The interventions under investigation include: General decrease in smartphone use (BEHAVIORAL), Avoiding Social Media Apps (BEHAVIORAL).

Who is sponsoring clinical trial NCT06361342?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06361342 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.